These cells include activated CD3ˉ/CD56+ NK cells, CD3+/CD56+ natural killer T (NKT) cells and CD3+/CD56ˉ T cells, which display a non‐MHC restricted cytotoxicity against a broad range of cancer cells.44 The gene discussed is NCAM1; the disease is cancer.